Pipeline development from Translational Biology Program Continued progress has been made on identifying new development candidates by Prana’s discovery chemistry group over the reporting period. These product candidates are within new generation chemical scaffolds and have demonstrated key attributes required to address neurodegenerative processes.
Prana continues to review other potentially suitable opportunities that may be highly attractive and can add significant shareholder value in the medium to longer term. "
Would the last sentence (which I have bolded) be a reference to the University of Qld paper?
PBT Price at posting:
4.0¢ Sentiment: Hold Disclosure: Held
